Research Papers

25 of 386 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SAR…
Hirabidian M; Bocket L; Demaret J; Vuotto F; Rabat A; Faure K; Labalette M; Hober D; Lefevre G; Alidjinou EK.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A mul…
Balmforth D; Swales JA; Silpa L; Dunton A; Davies KE; Davies SG; Kamath A; Gupta J; Gupta S; Masood MA; McKnight Á; Rees D; Russell AJ; Jaggi M; Uppal R.
J Clin Virol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Harmonization of SARS-CoV-2 reverse transcription quantitative PCR tests to the first WHO international standard for SA…
Sahoo MK; Huang C; Sibai M; Solis D; Pinsky BA.
J Clin Virol (Unknown)
Published: 2022
2/6 Transparent
Human coronaviruses: Origin, host and receptor.
Tang G; Liu Z; Chen D.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Humoral and cellular immune response levels at a 1-year follow-up after mild COVID-19.
Flieder T; Fischer B; von Bargen K; Peter A; Knabbe C; Birschmann I.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Hand, foot, and mouth disease outbreak by Coxsackievirus A6 during COVID-19 pandemic in 2021, São Paulo, Brazil.
Carmona RCC; Machado BC; Reis FC; Jorge AMV; Cilli A; Dias AMN; Morais DR; Leme L; Yu ALF; Silva MR; Carvalhanas TRMP; Timenetsky MCST.
J Clin Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international …
Arroyo Mühr LS; Eklund C; Lagheden C; Forslund O; Robertsson KD; Dillner J.
J Clin Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic.
Donoso Mantke O; Corman VM; Taddei F; McCulloch E; Niemeyer D; Grumiro L; Dirani G; Wallace PS; Drosten C; Sambri V; Niesters HGM.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A nationwide analytical and clinical evaluation of 44 rapid antigen tests for SARS-CoV-2 compared to RT-qPCR.
Schneider UV; Forsberg MW; Leineweber TD; Jensen CB; Ghathian K; Agergaard CN; Mortensen KK; Cohen A; Jørgensen CS; Larsen H; Hansen MB; Saleme U; Koch A; Kirkby NS; Kallemose T; Schaadt ML; Jensen FH; Jørgensen RL; Ma CMG; Steenhard N; Knudsen JD; Lisby JG; National Danish RAT testing group.
J Clin Virol (Unknown)
Published: 2022
2/6 Transparent
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observ…
Yang LM; Costales C; Ramanathan M; Bulterys PL; Murugesan K; Schroers-Martin J; Alizadeh AA; Boyd SD; Brown JM; Nadeau KC; Nadimpalli SS; Wang AX; Busque S; Pinsky BA; Banaei N.
J Clin Virol (Unknown)
Published: 2022
2/6 Transparent
A reverse-transcription droplet digital PCR assay to detect and quantify SARS-CoV-2 RNA in upper respiratory tract spec…
Milosevic D; Moyer AM; Majumdar R; Kipp BR; Yao JD.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Impact of rhinovirus on hospitalization during the COVID-19 pandemic: A prospective cohort study.
Scotta MC; Kern LB; Polese-Bonatto M; Azevedo TR; Varela FH; Zavaglia GO; Fernandes IR; de David CN; Fazolo T; da Costa MSC; de Carvalho FC; Sartor ITS; Zavascki AP; Stein RT.
J Clin Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
A qualitative RT-PCR assay for the specific identification of the SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern.
Corbisier P; Petrillo M; Marchini A; Querci M; Buttinger G; Bekliz M; Spiess K; Polacek C; Fomsgaard A; Van den Eede G.
J Clin Virol (Unknown)
Published: 2022
2/6 Transparent
Usefulness of real-time RT-PCR to understand the kinetics of SARS-CoV-2 in blood: A prospective study.
Zurita-Cruz ND; Martín-Ramírez A; Rodríguez-Serrano DA; González-Álvaro I; Roy-Vallejo E; De la Cámara R; Fontán García-Rodrigo L; Cardeñoso-Domingo L.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures.
Giraud-Gatineau A; Kaba L; Boschi C; Devaux C; Casalta JP; Gautret P; Chaudet H; Colson P; Raoult D.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
SARS-CoV-2 cycle threshold (Ct) values predict future COVID-19 cases.
Phillips MC; Quintero D; Wald-Dickler N; Holtom P; Butler-Wu SM.
J Clin Virol (Unknown)
Published: 2022
2/6 Transparent
Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays.
Quinton M; Geahr M; Gluck L; Jarrett J; Mostafa HH.
J Clin Virol (Unknown)
Published: 2022
2/6 Transparent
Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization.
Guo H; Fan Q; Song S; Shen S; Zhou B; Wang H; Cheng L; Ge X; Ju B; Zhang Z.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Clinical characterization of COVID-19 breakthrough infections, Philippines.
Velasco JM; Vila V; Diones PC; Valderama MT; Mendez C; Turao-Agoncillo MMM; Chinnawirotpisan P; Manasatienkij W; Joonlasak K; Klungthong C; Jones A; Fernandez S; Navarro FC.
J Clin Virol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
SARS-CoV-2 infections in mRNA vaccinated individuals are biased for viruses encoding spike E484K and associated with re…
Mostafa HH; Luo CH; Morris CP; Li M; Swanson NJ; Amadi A; Gallagher N; Pekosz A.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
SARS-CoV-2 transmitters have more than three times higher viral loads than non-transmitters - Practical use of viral lo…
Jajou R; Mutsaers-van Oudheusden A; Verweij JJ; Rietveld A; Murk JL.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Real-world Evaluation of a Sample Pooling Strategy for Large-Scale Rapid COVID-19 Testing.
Lee HR; Wang FY; Li JL; Chou TY; Ho HL.
J Clin Virol (Unknown)
Published: 2022
2/6 Transparent
Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France.
Lartigau M; Ouattara E; Tumiotto C; Wodrich H; Busson L; Trimoulet P; Thiel E; Nouzille M; Dubos M; Lafon ME; Gilleron V; Dehail P; Salles N; Malvy D.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
RSV reemergence in Argentina since the SARS-CoV-2 pandemic.
Dolores A; Stephanie G; Mercedes S NJ; Érica G; Mistchenko AS; Mariana V.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals.
Poopalasingam N; Korenkov M; Ashurov A; Strobel J; Fish I; Hellmich M; Gruell H; Lehmann C; Heger E; Klein F.
J Clin Virol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared